0
Skip to Content
PAREA
PAREA
Home
About ⌄
About
Members
Meet the Team
Learn ⌄
Why
FAQs
Governance ⌄
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group ⌄
About
Members
Events
Latest ⌄
News
Events
Videos
Support Us
PAREA
PAREA
Home
About ⌄
About
Members
Meet the Team
Learn ⌄
Why
FAQs
Governance ⌄
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group ⌄
About
Members
Events
Latest ⌄
News
Events
Videos
Support Us
Home
Folder: About ⌄
Back
About
Members
Meet the Team
Folder: Learn ⌄
Back
Why
FAQs
Folder: Governance ⌄
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group ⌄
Back
About
Members
Events
Folder: Latest ⌄
Back
News
Events
Videos
Support Us
  • Participation,
• 15/12/2023

Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023

Previous

Testimonial of Lauren Macdonald, cancer patient, delivered at the PsyPal launch event

Next

Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression

You Might Also Like

Related Embedded Video Item Thumbnail DAVOS: Brain Capital, Psychedelics & Human Flourishing
Related Embedded Video Item Thumbnail Testimonial of Lauren Macdonald, cancer patient, delivered at the PsyPal launch event
Related Embedded Video Item Thumbnail Presentation of the results of ketamine-assisted therapy program for treatment resistant depression
Related Embedded Video Item Thumbnail Ongoing trials investigating psychedelic-assisted therapies
Related Embedded Video Item Thumbnail Launch of the Psychedelic Access and Research European Alliance

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy